← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Universal Stabilization Technologies
San Diego, CA
$7,527,430
Total funding
10
Grants
Funding over time
peak $1.6M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,305,687 · 9
CDC$221,743 · 1
By mechanism
R44$2,416,419 · 2
R33$1,587,318 · 1
U01$1,194,078 · 1
R21$638,086 · 1
N01$599,749 · 1
R41$596,270 · 1
Investigators at Universal Stabilization Technologies
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution - Phase II$815,746
R44 · FY2018 · AI
Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines$633,988
R44 · FY2011 · AI
Adjuvant Development for a Thermostable Respiratory Influenza Vaccine$599,749
N01 · FY2018 · AI
Thermostable vaginal probiotic microbicide$544,412
R33 · FY2014 · AI
Thermostable vaginal probiotic microbicide$525,814
R33 · FY2015 · AI
Thermostable vaginal probiotic microbicide$517,092
R33 · FY2013 · AI
Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D$511,814
R44 · FY2010 · AI
Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution - Phase II$454,871
R44 · FY2017 · AI
Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis$446,001
U01 · FY2008 · AI
Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis$431,510
U01 · FY2006 · AI
Thermostable vaginal probiotic microbicide$332,766
R21 · FY2011 · AI
Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis$316,567
U01 · FY2007 · AI
Thermostable vaginal probiotic microbicide$305,320
R21 · FY2012 · AI
Thermostable Inactivated Potent Yellow Fever Vaccine$299,380
R41 · FY2021 · AI
Thermostable Inactivated Potent Yellow Fever Vaccine$296,890
R41 · FY2022 · AI
Development of a thermostable, electron beam inactivated Sabin-based polio vaccine for mucosal delivery$221,743
R43 · FY2018 · IP
Development of a thermostable rotavirus vaccine for mucosal delivery without need for reconstitution$147,981
R43 · FY2015 · AI
Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D$125,786
R43 · FY2008 · AI